focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRLM.L Regulatory News (RLM)

  • There is currently no data for RLM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Block listing Interim Review

16 Feb 2018 07:00

RNS Number : 3663E
Realm Therapeutics PLC
16 February 2018
 

Realm Therapeutics plc

Block Listing Interim Review

 

Pursuant to AIM Rule 29 and Schedule 6 of the AIM Rules for Companies Realm Therapeutics plc makes the following update on its block listing:

 

Date: 16 February 2018

 

Name of applicant:

Realm Therapeutics plc

Name of scheme:

Executive Omnibus Incentive Plan

Warrants

Figures for all schemes relate to ordinary shares of 10 pence each

Period of return:

From: 18 August 2017 To: 15 February 2018

Balance of unallotted securities under scheme(s) from previous return:

2,055,362

117,195

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

Nil

21,139,826

Less: Number of securities issued/allotted under scheme(s) during period:

Nil

Nil

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

2,055,362

21,257,021

 

Number and class of securities originally admitted:* these securities have been adjusted for a 1 for 10 share consolidation which took effect on 2 July 2010

*20,000 and *378,423 + *32,000 and 200,000

*196,087 and *21,108

Dates of Admission:

7 August 2006 and 31 August 2007 and 15 August 2012

7 August 2006 and 31 August 2007

Name of contact:

Marella Thorell, Company Secretary

Telephone number of contact:

+1 484-321-2749

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BLRBUGDDCUGBGII
Date   Source Headline
11th Jun 20072:32 pmRNSPresenting at Conference
11th Jun 200712:18 pmRNSHolding(s) in Company
31st May 200710:14 amRNSResult of AGM
23rd May 200712:00 pmBUSFDA Lists Sterilox Food Safety Solution for Food Contact
23rd May 20077:02 amRNSRe: Food Safety Solution
21st May 200712:00 pmBUSStudy Shows PuriCore's Aquatine(TM) EC Effective for Root Canal Disinfecting and Cleansing
14th May 20075:57 pmRNSAnnual Information Update
25th Apr 20079:14 amRNSDirector/PDMR Shareholding
19th Apr 200710:45 amRNSHolding(s) in Company
19th Apr 20079:54 amRNSDirector/PDMR Shareholding
18th Apr 20074:00 pmRNSHolding(s) in Company
18th Apr 20077:01 amRNSDirector/PDMR Shareholding
16th Apr 20077:02 amRNSFinal Results
5th Apr 200712:00 pmBUSPuriCore Receives FDA 510(k) Approval for Endoscope Disinfectant System in US
5th Apr 20077:01 amRNSFDA 510(k) Approval
29th Mar 20078:00 amRNSNotice of Results
27th Mar 20071:54 pmBUSPuriCore signs additional endoscope reprocessor marketing partnership
27th Mar 20071:02 pmRNSSigns Marketing Partnership
5th Mar 20075:12 pmRNSHolding(s) in Company
5th Feb 20077:01 amRNSRe Agreement
5th Feb 20077:01 amRNSTrading Update
26th Jan 20073:44 pmRNSRe: Section 198
8th Jan 20077:00 amRNSFundraising
18th Dec 20064:01 pmRNSTransparency Rule
8th Dec 20062:00 pmRNSGreg Bosch Wins CEO of Year
13th Nov 20067:02 amRNSAppointment
7th Nov 20063:47 pmRNSRe Interest in Shares
7th Nov 20063:44 pmRNSInterest in Shares
13th Sep 20067:03 amRNSAppointments
13th Sep 20067:03 amRNSContract
13th Sep 20067:03 amRNSInterim Results
21st Aug 200611:05 amRNSHolding(s) in Company
16th Aug 200611:12 amRNSNotice of Results
7th Aug 20063:43 pmRNSBlocklisting Applications

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.